Page last updated: 2024-09-03

trapoxin a and Teratocarcinoma

trapoxin a has been researched along with Teratocarcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beppu, T; Horinouchi, S; Kijima, M; Sugita, K; Yoshida, M	1

Other Studies

1 other study(ies) available for trapoxin a and Teratocarcinoma

Article	Year
Trapoxin, an antitumor cyclic tetrapeptide, is an irreversible inhibitor of mammalian histone deacetylase. The Journal of biological chemistry, 1993, Oct-25, Volume: 268, Issue:30 Topics: 3T3 Cells; Amino Acid Sequence; Animals; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Cell Cycle; Cell Division; Cell Transformation, Neoplastic; G1 Phase; Histone Deacetylase Inhibitors; Hydroxamic Acids; Kinetics; Mammary Neoplasms, Experimental; Mice; Molecular Sequence Data; Molecular Structure; Oncogenes; Peptides; Teratocarcinoma; Tumor Cells, Cultured	1993

Article

Year

Trapoxin, an antitumor cyclic tetrapeptide, is an irreversible inhibitor of mammalian histone deacetylase.

The Journal of biological chemistry, 1993, Oct-25, Volume: 268, Issue:30

Topics: 3T3 Cells; Amino Acid Sequence; Animals; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Cell Cycle; Cell Division; Cell Transformation, Neoplastic; G1 Phase; Histone Deacetylase Inhibitors; Hydroxamic Acids; Kinetics; Mammary Neoplasms, Experimental; Mice; Molecular Sequence Data; Molecular Structure; Oncogenes; Peptides; Teratocarcinoma; Tumor Cells, Cultured

1993